We can’t show the full text here under this license.
Abstract
Obesity is linked to unique shifts in gut microbiota, including increased pro-inflammatory bacteria compared to non-obese children.
- The gut microbiome is crucial for intestinal health, influencing mucus production and regulating short-chain fatty acid production.
- , or microbiome imbalance, is associated with increased appetite and the development of metabolic disorders that contribute to obesity.
- Childhood obesity is correlated with specific alterations in gut microbiota composition.
- Potential therapeutic approaches include , , synbiotics, and dietary interventions such as Mediterranean and ketogenic diets.
- The integration of microbial metabolites with medications like orlistat and semaglutide may help restore microbial balance.
- Further clinical trials are needed to determine the optimal treatment protocols for adjusting the gut microbiome in obesity management.
Simplified